NCT06206902 2024-02-23
F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Shanghai Simnova Biotechnology Co.,Ltd.
Phase 1 Unknown
Clinical Trials
12 trialsNCT04764513 2022-03-28
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT02856048 2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3 Unknown
NCT04134247 2019-10-22
Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL
Shandong Provincial Hospital
Phase 4 Unknown
NCT02451774 2018-05-09
PTX-II
University of Guadalajara
Phase 2/3 Unknown
NCT03383406 2017-12-26
IVAM
Asan Medical Center
Phase 2 Unknown
NCT03062072 2017-04-07
ECHO
National Cancer Center, Korea
Unknown
NCT02145923 2015-06-10
Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis
Burnasyan Federal Medical Biophysical Center
Phase 1/2 Unknown
NCT00725231 2012-05-07
A-CHOP-14
University of Göttingen
Phase 3 Unknown
NCT00179816 2010-10-11
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1/2 Unknown
NCT00109356 2007-05-07
Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia
Novacea
Phase 1/2 Unknown
NCT00435955 2007-02-16
Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma
Azienda Ospedaliera San Giovanni Battista
Phase 3 Unknown